Sanara MedTech Inc. 8-K

What Happened

• Sanara MedTech Inc. announced its financial results for the quarter and fiscal year ended December 31, 2025, by issuing a press release on March 24, 2026. The press release is furnished as Exhibit 99.1 to the company’s Form 8-K (Item 2.02), which reports results of operations and financial condition.
• The company’s Form 8-K notes that the press release is being furnished (not “filed”) under the Exchange Act and therefore is not subject to the liabilities of Section 18 nor automatically incorporated by reference into other securities filings.

Key Details

• Filing date: March 24, 2026 (Form 8-K reporting results under Item 2.02).
• Period covered: quarter and fiscal year ended December 31, 2025.
• Exhibit: Press Release furnished as Exhibit 99.1 to the 8-K.
• Legal note: Information is “furnished” and not deemed “filed” for certain Exchange Act purposes.

Why It Matters

• This 8-K signals Sanara MedTech has released its latest earnings and year-end financial results—important information for investors evaluating recent revenue, profitability, and company trends. Because the 8-K does not include the financial figures themselves in the filing text, investors should read the furnished press release (Exhibit 99.1) and any related filings (e.g., quarterly or annual reports) for the detailed numbers and management commentary.